Literature DB >> 17418101

Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes.

Kiyoharu Ito1, Yoshihiro Anada, Motohiro Tani, Mika Ikeda, Takamitsu Sano, Akio Kihara, Yasuyuki Igarashi.   

Abstract

Platelets are known to store a large amount of the bioactive lipid molecule sphingosine 1-phosphate (S1P) and to release it into the plasma in a stimuli-dependent manner. Erythrocytes can also release S1P, independently from any stimuli. We measured the S1P and sphingosine (Sph) levels in erythrocytes by HPLC and found that the contribution of erythrocyte S1P to whole blood S1P levels is actually higher than that of platelets. In vitro assays demonstrated that erythrocytes possess much weaker Sph kinase activity compared to platelets but lack the S1P-degrading activities of either S1P lyase or S1P phosphohydrolase. This combination may enable erythrocytes to maintain a high S1P content relative to Sph. The absence of both S1P-degrading enzymes has not been reported for other cell types. Thus, erythrocytes may be specialized cells for storing and supplying plasma S1P.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418101     DOI: 10.1016/j.bbrc.2007.03.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  84 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice.

Authors:  Shigetomo Fukuhara; Szandor Simmons; Shunsuke Kawamura; Asuka Inoue; Yasuko Orba; Takeshi Tokudome; Yuji Sunden; Yuji Arai; Kazumasa Moriwaki; Junji Ishida; Akiyoshi Uemura; Hiroshi Kiyonari; Takaya Abe; Akiyoshi Fukamizu; Masanori Hirashima; Hirofumi Sawa; Junken Aoki; Masaru Ishii; Naoki Mochizuki
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

5.  S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release.

Authors:  Karin Golan; Yaron Vagima; Aya Ludin; Tomer Itkin; Shiri Cohen-Gur; Alexander Kalinkovich; Orit Kollet; Chihwa Kim; Amir Schajnovitz; Yossi Ovadya; Kfir Lapid; Shoham Shivtiel; Andrew J Morris; Mariusz Z Ratajczak; Tsvee Lapidot
Journal:  Blood       Date:  2012-01-25       Impact factor: 22.113

Review 6.  Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Authors:  Athanasia Skoura; Timothy Hla
Journal:  Cardiovasc Res       Date:  2009-03-15       Impact factor: 10.787

Review 7.  The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function.

Authors:  Michael D Davis; John H Kehrl
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).

Authors:  Yong-Moon Lee; Krishnan Venkataraman; Sun-Il Hwang; David K Han; Timothy Hla
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-08-06       Impact factor: 3.072

Review 9.  Visualizing S1P-directed cellular egress by intravital imaging.

Authors:  Christina C Giannouli; Panagiotis Chandris; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2013-10-01

Review 10.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.